Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Lansoprazole
Primecrown 2010 Limited
A02BC; A02BC03
Lansoprazole
30 milligram(s)
Orodispersible tablet
Product subject to prescription which may be renewed (B)
Proton pump inhibitors; lansoprazole
Authorised
2010-06-04
ZOTON ® FASTAB 15 MG ORO-DISPERSIBLE TABLETS ZOTON ® FASTAB 30 MG ORO-DISPERSIBLE TABLETS Lansoprazole PACKAGE LEAFLET: INFORMATION FOR THE USER READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Zoton is and what it is used for 2. What you need to know before you take Zoton 3. How to take Zoton 4. Possible side effects 5. How to store Zoton 6. Contents of the pack and other information 1. WHAT ZOTON IS AND WHAT IT IS USED FOR The active ingredient in Zoton is lansoprazole, which is a proton pump inhibitor. Proton pump inhibitors reduce the amount of acid that your stomach makes. Your doctor may prescribe Zoton for the following indications: - Treatment of duodenal and stomach ulcer - Treatment of inflammation in your oesophagus (reflux oesophagitis) - Prevention of reflux oesophagitis - Treatment of heartburn and acid regurgitation - Treatment of infections caused by the bacteria _Helicobacter pylori _when given in combination with antibiotic therapy - Treatment or prevention of duodenal or stomach ulcer in patients requiring continued NSAID treatment (NSAID treatment is used against pain or inflammation) - Treatment of Zollinger-Ellison syndrome. Your doctor may have prescribed Zoton for another indication or with a dose different from that which is written in this information leaflet. Please follow your doctor’s instructions for taking your medicine. You must talk to a doctor if you do not feel better or if you feel worse after 14 days. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ZOTON DO NOT Read the complete document
Health Products Regulatory Authority 18 January 2019 CRN008QDJ Page 1 of 3 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zoton FasTab 30mg oro-dispersible tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each oro-dispersible tablet contains 30mg of lansoprazole. Excipient(s) with known effect: Each 30 mg oro-dispersible tablet contains lactose and aspartame (E951). For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Oro-dispersible tablet _Product imported from UK:_ White to yellowish white, circular, flat bevelled-edge oro-dispersible tablet with ‘30’ debossed on one side. Each oro-dispersible tablet contains orange to dark brown microgranules. 4 CLINICAL PARTICULARS As per PA0822/101/003 5 PHARMACOLOGICAL PROPERTIES As per PA0822/101/003 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Lactose monohydrate Microcrystalline cellulose Magnesium carbonate Low substituted hyprolose Hyprolose Hypromellose Titanium dioxide (E171) Talc Mannitol Health Products Regulatory Authority 18 January 2019 CRN008QDJ Page 2 of 3 Methacrylic acid-ethyl acrylate copolymer (1:1) dispersion 30 per cent Polyacrylate dispersion 30 per cent Macrogol 8000 Glycerol monostearate Polysorbate 80 Triethyl citrate Citric acid anhydrous Crospovidone Magnesium Stearate Aspartame (E951) Strawberry Flavour Iron oxide red (E172) Iron oxide yellow (E172) 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product is the date shown on the blister strips and outer carton of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25˚C. Store in the original package in order to protect from moisture 6.5 NATURE AND CONTENTS OF CONTAINER Aluminium blisters in an over-labelled cardboard carton containing 28 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER Primecrown 2010 Limited 4/5 Northolt Trading Estate Belvue Road Northolt Middlesex UB5 5QS Read the complete document